Publisher Correction: Allogeneic CD5-specific CAR-T therapy for relapsed/refractory T-ALL: a phase 1 trial

Correction to: Nature Medicine https://doi.org/10.1038/s41591-024-03282-2, published online 1 October 2024.

In the version of the article initially published, in Table 1, the “EO14” row was included in cohort B when it should have been part of cohort A. The amended table can now be found in the HTML and PDF versions of the article.